Objective: To determine the impact of advanced age as a predictor of biochemical recurrence after radical prostatectomy in Japanese patients with regard to pathological stage. Methods: We retrospectively evaluated 379 Japanese patients with pT2-3N0/X prostate cancer undergoing radical prostatectomy from 2000 to 2010 at a single academic institution. Cox proportional hazards model was used to determine whether advanced age is a predictor of biochemical recurrence according to pathological stage. Results: The mean age at radical prostatectomy was 65.8 years. With a mean follow-up of 49.8 months, 61 men (16.1%) experienced biochemical recurrence. Martingale residual analysis showed that the adverse prognostic effect of age on biochemical recurrence fits a linear model, and patients were classified into two groups using a cut-off point of age 70 years. Although older patients had higher rates of biochemical recurrence than younger ones in the case of pT2 patients (P ¼ 0.049), advanced age itself was not an independent predictor of biochemical recurrence among the total cohort. However, especially in pT2 patients with negative surgical margins, advanced age was an independent predictor of biochemical recurrence (HR ¼ 3.97, P ¼ 0.006). In these patients, 2-and 5-year biochemical recurrence-free survival rates were 98.0 and 92.4% for younger patients and 93.2 and 82.0% for older patients, respectively (log-rank P ¼ 0.015). On the other hand, in pT3 patients, there was no significant association between age and biochemical recurrence. Conclusions: Advanced age is an independent predictor of biochemical recurrence after radical prostatectomy in Japanese patients with stage pT2 disease and negative surgical margins. Moreover, older patients of this group tended to have recurrence more than 2 years after surgery.
INTRODUCTION
With the global population aging, many elderly patients with a long life expectancy present with prostate cancer (PCa) (1) . Definitive treatment is recommended in patients with life expectancy of !10 years according to the NCCN guidelines (2) . Radical prostatectomy (RP), as a standard treatment option, has been performed on elderly men worldwide (3 -8) . Although it is well known that older age is a positive predictor of PCa detection at biopsy (9, 10) , the role of age in PCa prognosis is still controversial. The increase in the proportion of adverse tumor-related prognostic factors is relatively consistent with increasing age (3 -8) . Some studies showed that advanced age (!70 years) was independently associated with a higher risk of biochemical recurrence (BCR) in patients treated with RP (3, 4) , while other studies failed to find a link (5 -8) . Therefore, it is as yet unknown whether advanced age itself could be a biological indicator of the aggressiveness of PCa beyond the influence of adverse pathological characteristics, possibly due to later diagnosis.
Japan is experiencing a rapidly aging population, with the proportion of people aged over 65 years the highest in the world (23% in 2009) (11) . The mean life expectancy for Japanese men at the ages of 70 and 75 years is 15.1 and 11.6 years, respectively (12) . According to the data from population-based cancer registries, in 2020 the highest increase in the incidence rate among cancers of various organs will be of PCa (13) . However, until now there have been no studies on the association between advanced age at RP and PCa prognosis in Japanese patients.
Based on the above considerations, we assessed the impact of advanced age at RP on the risk of BCR in Japanese men with respect to pathological stage. We especially focused on a subpopulation of patients with pT2 (organ-confined) and negative surgical margins as favorable pathological findings to clarify the biological role of advanced age.
PATIENTS AND METHODS
After obtaining institutional review board approval, we retrospectively reviewed data on 528 Japanese patients with pT2-3pN0/X PCa treated with minimum incision endoscopic RP (MIES-RP) between December 2000 and August 2010 at our institution (14 -16) . This technique is a gasless, singleport access, cost-effective and minimally invasive surgery that was first reported by Kihara et al. (14, 15) .
Patients who were treated with neoadjuvant androgen deprivation therapy (n ¼ 107), those who were diagnosed by transurethral resection of the prostate (n ¼ 4), those who were followed-up for less than 12 months (n ¼ 27) and those whose prostate-specific antigen (PSA) values never decreased to less than 0.2 ng/ml after RP to evaluate the association between age and BCR accurately (n ¼ 11) were excluded from this study, leaving 379 patients for analysis.
As the hospital is a training institution, surgical procedures were performed by multiple surgeons. When procedures were performed by a less-experienced surgeon, the procedure was supervised by a high-volume surgeon, who served as the first assistant during the surgery. From 2004, pelvic lymph node dissection (PLND) has been frequently omitted based on biopsy information, clinical stage and PSA. We principally omitted PLND in patients with biopsy GS 3 þ 4, cT1c-cT2a and PSA ,10 ng/ml. Preliminary studies indicated that performance of PLND was not a predictor of PSA recurrence on multivariate analysis (data not shown). Written informed consent was obtained from all patients before RP.
RP specimens were surface inked and processed as described previously (17) . GS, pathological stage, positive surgical margins, lymphovascular invasion and index cancer volume in the RP specimens were recorded. All biopsy and RP specimens were re-evaluated by a single pathologist according to the 2005 International Society of Urological Pathology consensus (18) . Pathological stage was defined according to the 2002 American Joint Committee on Cancer staging classification (19) . Positive surgical margins were defined as the presence of any cancer cells at the inked surface of the resected specimens. Lymphovascular invasion was defined as cancer cells in an endothelium-lined space. Index cancer volume was calculated by using the formula: 0.4 Â length Â width Â cross-section thickness (multiplication of number of cross sections with section thickness) (20) .
In the current study, the following clinicopathological variables were evaluated: body mass index, Charlson's comorbidity index, preoperative PSA (log-transformed, Tandem R until February 2003 and Tosoh PSA II thereafter), extracapsular extension, seminal vesicle invasion, surgical margin status, pathological GS, lymphovascular invasion, PLND and index cancer volume.
After RP, PSA was usually measured at least every 3 months during year 2, every 6 months during years 3 -5 and yearly thereafter. Patients were observed without any treatment until BCR was confirmed. BCR was defined as two consecutive PSA values of 0.2 ng/ml or greater. The date of BCR was defined as the date of the first PSA value of 0.2 ng/ml or greater after RP. Patients without failure were censored at the date of the last PSA value.
Differences in the distribution of clinicopathological variables between groups were assessed using Student's t-test for continuous variables and chi-square test for categorical variables. Martingale residual analysis was conducted to evaluate the functional form of age to be used in the Cox proportional hazards model and determine the optimal cut-off point of age as predictors of BCR. In short, age was fitted to the Cox proportional hazards model without the covariate of interest, and Martingale residuals were calculated. Then we drew a scatter plot of age vs Martingale residuals from the Cox proportional hazards model. Next, a smoothed fit of the scatter plot was applied to check the functional form in the Cox proportional hazards model. Based on this finding, we determined the optimal cut-off point of age and classified subjects into two groups. If a remarkable buckling of the curve is shown, a cut-off point or another nonlinear dependency should be considered. If the curve is linear and there is no abrupt increase in the hazard for BCR, cut-off points can be arbitrarily set. Univariate and multivariate Cox proportional hazards model analyses were performed to determine risk factors related to BCR. BCR-free survival was evaluated using the Kaplan -Meier method and the log-rank test. All statistical analyses were performed using JMP 9.0.2 (SAS Institute, Inc., Cary, NC, USA) and R version 2.14.1 (the R Project for Statistical Jpn J Clin Oncol 2013;43 (4) 411
Computing, www.r -project.org). Two-tailed P , 0.05 was considered to be statistically significant.
RESULTS
The characteristics of the total cohort are as follows. The mean follow-up was 49.8 months (median 43.9 months). The mean age was 65.8 years (median 66.0 years). The mean and median preoperative PSA levels were 8.4 and 7.0 ng/ml. Extracapsular extension, seminal vesicle invasion, positive surgical margins and lymphovascular invasion were observed in 123 (32.5%), 15 (4.0%), 96 (25.3%) and 102 (26.9%) of the 379 patients, respectively. Martingale residual analysis was conducted to evaluate the functional form of age to be used in the Cox proportional hazards model. It showed that the adverse prognostic effect of age on BCR fits into a linear model (Supplementary data, Fig. 1 ). There is no abrupt increase in the hazard for BCR (Supplementary data, Fig. 1 ). Thus, it is possible to set the cut-off point of age arbitrarily. Based on this finding, we set a cut-off point of age as 70 years and classified subjects into two groups (,70 years or !70 years), since many papers used this cut-off value (3, 4, 7, 8) . Of the total, 256 men (67.5%) were younger than 70 years and the remaining 123 men (32.5%) were 70 years or older. A higher proportion of older patients had stage pT3 disease (41.5 vs 29.3%; P ¼ 0.020) and lymphovascular invasion (35.8 vs 22.7%; P ¼ 0.008) compared with younger patients. Moreover, older patients had larger cancer volume than younger patients (P ¼ 0.006). No differences were found between younger and older patients on surgical margin status and pathological GS (Data not shown).
The baseline clinical and pathological characteristics in pT2 patients between the age groups are shown in Table 1 . Older patients have lower body mass index and higher Charlson comorbidity index (P ¼ 0.007 and 0.048, respectively). In addition, older patients have significantly larger index cancer volume (P ¼ 0.016). No significant differences were found in preoperative PSA, surgical margin status, pathological GS, lymphovascular invasion, PLND and follow-up time between the age groups. BCR was more common in older patients than in younger patients (P ¼ 0.046). Meanwhile, in pT3 patients, all baseline characteristics showed no differences between the age groups (Table 1) .
Overall, 61 patients (16.1%) experienced BCR. As shown in Table 2 , in multivariate Cox proportional hazards analysis, advanced age was not a predictor of BCR (P ¼ 0.911), although Charlson comorbidity index, positive surgical 
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Advanced age and prostate cancer margins and lymphovascular invasion were significant predictors of BCR (P ¼ 0.034, ,0.001 and 0.008, respectively). The 2-and 5-year BCR-free survival rates were 92.3 and 81.6% for younger patients and 90.8 and 80.7% for older patients, respectively (Fig. 1A) . Using the log-rank test, there was no significant difference between the age groups (log-rank P ¼ 0.353).
After stratification by pathological stage, in pT2 patients, advanced age was associated higher rates of BCR on univariate analysis (P ¼ 0.049), but it was not a predictor of BCR on multivariate analysis [hazard ratio (HR) ¼ 1.87, P ¼ 0.131; Table 2 ], along with positive surgical margins and pathological GS (P ¼ 0.002 and 0.032, respectively). The BCR-free survival rates were significantly lower in older Jpn J Clin Oncol 2013;43 (4) 413 patients with the 2-and 5-year BCR-free survival rates of 97.0 and 89.2% for younger patients and 92.8 and 79.1% for older patients, respectively (log-rank P ¼ 0.039; Fig. 1B) . In pT3 patients, advanced age was not a predictor of BCR both on univariate and multivariate analysis (P ¼ 0.200 and 0.277, respectively; Table 2 ). The BCR-free survival rates were similar between the age groups (log-rank P ¼ 0.207). We further examined the impact of advanced age on BCR in pT2 patients with negative surgical margins. In the total of 223 patients with stage pT2 disease and negative surgical margins, 20 patients (9.0%) experienced BCR. Advanced age was a significant and independent predictor of BCR on multivariate analysis in this group (HR ¼ 3.93, P ¼ 0.006; Table 3 ). The BCR-free survival rates were significantly lower in older patients with the 2-and 5-year BCR free survival rated of 98.0 and 92.4% for younger patients and 93.2 and 82.0% for older patients, respectively (log-rank P ¼ 0.015; Fig. 1C ). As shown in Fig. 1C , older patients with stage pT2 disease and negative surgical margins tended to have recurrence more than 2 years after surgery.
DISCUSSION
It is well known that advanced age has a positive association with risks of PCa and high-grade disease at biopsy (9, 10) and that, among PCa patients, elderly men tend to have higher stage and higher grade disease (3 -8) . The latter finding is compatible with our finding that older patients had more stage pT3 disease, more lymphovascular invasion and larger index cancer volume than younger patients in the current study. Moreover, in pT2 patients, older patients had significantly larger cancer volume than younger patients. These findings are partly because undiagnosed PCa might have naturally progressed over time in older patients.
On the other hand, recent several studies regarding association between age and PCa prognosis following RP showed inconsistent results, i.e. some papers have reported that advanced age was an independent predictor of BCR after RP (3, 4), while it was not in others (5 -8) . In the current study, advanced age was not associated with higher risk of BCR in the total cohort, supportive of several previous studies (5 -8) . Although, in pT2 patients, older patients experienced BCR more frequently than younger patients did (P ¼ 0.049), advanced age was not an independent predictor on multivariate analysis. When focusing on stage pT2 patients with negative surgical margins, we found that advanced age was an independent predictor of BCR (P ¼ 0.049). Older patients with stage pT2 disease and negative surgical margins had higher risk of BCR after RP but tended to have recurrence more than 2 years after surgery, with 2-and 5-year BCR-free survival rates of 93.2 and 82.0%, respectively. Meanwhile, in pT2 patients with positive surgical margins and pT3 patients, irrespective of age, a moderate number of patients had recurrence within 2 years after surgery, with 2-year BCR-free survival rates of 85.8 and 83.7%, respectively (data not shown). Patients who experienced BCR within 2 years after RP have a significantly higher mortality rate than patients who had BCR more than 2 years after surgery (21) . Therefore, advanced age could modestly exert its 
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Advanced age and prostate cancer prognostic influence as an adverse predictor of BCR in patients with stage pT2 disease and negative surgical margins. However, the prognostic significance of advanced age is relatively weak compared with other adverse pathological factors, such as positive surgical margins and high pT stage, and thus might be diminished readily by their strong influences. Several hypotheses can be suggested to explain the mechanism that advanced age was an independent predictor in pT2 patients with negative surgical margins. First, advanced age could be associated with reduced host defense against cancer (22) . Secondly, elderly men tend to have low levels of serum testosterone (23) . A number of reports have shown that low systemic testosterone level is associated with aggressive PCa (24) . It has been reported that lower than normal preoperative serum testosterone level was an independent predictor of treatment failure following RP (25) . These findings suggest a possible role of steroid sex hormones in the contribution of advanced age to poor prognosis after RP. Thirdly, it has been hypothesized that chronic inflammatory status caused by aging could be a mechanism that relates advanced age to cancer (26, 27) . Advanced age could induce the production of various inflammatory mediators, such as interleukin (IL)-6, tumor necrosis factor (TNF)-a and IL-10, and as a result could facilitate carcinogenesis and progression of cancer cells (27) . Cyclooxygenase, a key enzyme producing inflammatory mediator prostaglandins, could be overexpressed in older people and promote cancer growth in PCa (26) (27) (28) .
Higher Charlson comorbidity index was associated with lower rates of BCR in the current study. Patients with higher Charlson comorbidity index could take many medications due to their comorbidies, such as diabetes mellitus, hypertension, dyslipidemia, ischemic heart disease and cerebral infarction. Thus, several medications, such as aspirin, metformin and statins, might have anti-cancer effects on PCa progression in this group (29-31).
The current study has some limitations. First, selection bias could not be ruled out because the study was based on a referred cohort. Prospective studies are warranted in order to validate our results. Secondly, small cohort size could have influence on our results. Thus, our findings should be confirmed in larger cohorts. Thirdly, RP was performed by multiple surgeons, including resident surgeons. Surgical volume has been reported to influence pathological outcomes and BCR-free survival after RP (32) . However, our results seem to reflect the routine clinical practice and the real-world settings of contemporary hospitals. Fourthly, we used index cancer volume as a measure of cancer volume in the current study. In multifocal disease, the index lesion determines disease progression and secondary lesions do not contribute to clinical outcome (33) . Therefore, calculating the index cancer volume alone could be sufficient. Finally, PSA was used as surrogate marker for disease recurrence and we did not focus on clinical endpoints such as distant metastases and cancer-specific mortality, although D'Amico et al. showed that men with BCR are at higher risk of dying from PCa (34) .
In conclusion, the current study, for the first time, revealed the prognostic role of advanced age for Japanese patients who underwent RP. Advanced age was not predictive of BCR in the total cohort, whereas it was an independent predictor of BCR in pT2 patients with negative surgical margins, suggesting the biological role of advanced age on PCa progression. Older patients with stage pT2 disease and negative surgical margins tended to have recurrence more than 2 years after surgery. Further research is necessary to confirm our results in other races and in larger and prospective cohorts.
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